Associations between consumption of coffee and caffeinated soft drinks and late stillbirth-Findings from the Midland and North of England stillbirth case-control study.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 18 06 2020
revised: 05 10 2020
accepted: 08 10 2020
pubmed: 22 11 2020
medline: 15 5 2021
entrez: 21 11 2020
Statut: ppublish

Résumé

The consumption of caffeinated drinks and soft drinks is widespread in society, including by pregnant women. Data regarding the association of caffeine intake and stillbirth are varied. We aimed to investigate the degree of consumption of caffeinated drinks or soft drinks in the last four weeks of pregnancy in women who experienced a late stillbirth compared to women with ongoing live pregnancies at similar gestation. Influences on maternal caffeine intake and soft drink consumption during pregnancy were also investigated. A case-control study undertaken in 41 maternity units in the United Kingdom. Cases were women who had a singleton non-anomalous stillbirth ≥28 weeks' gestation (n = 290) and controls were women with an ongoing pregnancy at the time of interview (n = 729). Data were collected using an interviewer-administered questionnaire which included questions regarding consumption of a variety of caffeinated drinks and soft drinks in the last four weeks of pregnancy as well as other behaviours (e.g. cigarette smoking). Multivariable analysis adjusting for co-existing demographic and behavioural factors found the consumption of instant coffee, energy drinks and cola were associated with increased risk of stillbirth. There was an independent association between caffeine intake and late stillbirth (adjusted Odds Ratio 1.27, 95 % Confidence Interval (95 %CI) 1.14, 1.43 for each 100 mg increment/day). 15 % of cases and 8% of controls consumed more than the World Health Organisation (WHO) recommendation (>300 mg of caffeine/day; aOR 2.30, 95 % CI 1.40, 4.24). The population attributable risk for stillbirth associated with >300 mg of caffeine/day was 7.4 %. The majority of respondents reduced caffeine consumption in pregnancy. Midwives and internet resources were the most frequently used sources of information which influenced maternal behaviour with regard to soft drinks and caffeine, and this did not differ between cases and controls. Women should be informed that consumption of caffeine during pregnancy is associated with increased risk of stillbirth, particularly at levels greater than recommended by the WHO (>300 mg/day). Recommendations from midwives and internet-based resources are likely to be the most effective means to influence maternal behaviour.

Identifiants

pubmed: 33218821
pii: S0301-2115(20)30645-X
doi: 10.1016/j.ejogrb.2020.10.012
pii:
doi:

Substances chimiques

Coffee 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

471-477

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Alexander E P Heazell (AEP)

Maternal and Fetal Health Research Centre, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom; St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom. Electronic address: alexander.heazell@manchester.ac.uk.

Kate Timms (K)

Maternal and Fetal Health Research Centre, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom; Lydia Becker Institute of Inflammation and Immunology, Faculty of Biology, Medicine & Health, University of Manchester, United Kingdom.

Rebecca E Scott (RE)

Maternal and Fetal Health Research Centre, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.

Lauren Rockliffe (L)

Manchester Centre for Health Psychology, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.

Jayne Budd (J)

St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Minglan Li (M)

Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.

Robin Cronin (R)

Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.

Lesley M E McCowan (LME)

Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.

Edwin A Mitchell (EA)

Department of Paediatrics: Child Health and Youth Health, University of Auckland, Auckland, New Zealand.

Tomasina Stacey (T)

School of Human and Health Sciences, University of Huddersfield, Huddersfield, United Kingdom; Calderdale and Huddersfield NHS Foundation Trust, Lindley, Huddersfield, United Kingdom.

Devender Roberts (D)

Liverpool Women's Hospital NHS Foundation Trust, Crown Street, Liverpool, United Kingdom.

John M D Thompson (JMD)

Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand; Department of Paediatrics: Child Health and Youth Health, University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH